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Introduction
Community-acquired pneumonia (CAP) is one of the primary
causes of sepsis, septic shock, acute respiratory distress
syndrome (ARDS), and multiple organ dysfunction syndrome
(MODS) [1-3]. The chain of immune responses in patients
with pneumonia can be considered as a continuum of disease
from an initial appropriate response in patients with CAP,
to a deleterious response that encompasses Severe CAP,
Sepsis, Septic Shock, ARDS and MODS. As the lung infection
overwhelms the natural defenses that are produced by
physiologic pulmonary and systemic inflammation, a deeper
line of defense is necessary. At this point, the immune system
may develop an inflammatory response that may be damaging
to vital organs, culminating with organ failure. In this opinion
piece I will review the pathophysiology of CAP and construct a
continuum of disease from CAP to MODS.

Figure 1. A schematic representation of the alveolar space, containing
the alveolar macrophage as well as the normal alveolar flora.

Pathophysiology of CAP
In a prior opinion piece in the Journal of Respiratory Infections,
I stated that the pathogenesis of CAP is evolving as we recognize
that the lower respiratory tract is not sterile as we previously
considered [4]. A schematic representation of the alveolar
space, containing the alveolar macrophage as well as the
normal alveolar flora, is depicted in Figure 1. The concept that
organisms should first arrive to the alveoli as the first step in
the pathogenesis of CAP may not be necessary in all patients.
Multiplication of bacteria or viruses already present in the
alveoli, as part of the normal flora, may be an important etiology
of CAP. The traditional typical and atypical pathogens able to
cause CAP are not considered as part of the normal alveolar flora.
For these organisms, the first step in the pathogenesis of CAP is
their arrival to the alveolar space primarily via microaspiration
of oropharyngeal secretions (Figure 2).

Figure 2. Arrival of S. pneumoniae to the alveolar space via
microaspiration of oropharyngeal secretions.
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Figure 3. Alveolar macrophage phagocytosis of S. pneumoniae and
production of cytokines and chemokines.

Figure 4. Alveolar macrophage phagocytosis of S. pneumoniae and
production of cytokines and chemokines.

Figure 5. The physiologic host local and systemic response characterize
patients with mild to moderate CAP.

Figure 6. The host dysregulated inflammatory response indicates that
the patient develops sepsis. At this point the patient is consider to have
Severe CAP.

The alveolar macrophages are professional phagocytes
that represent an important defense mechanism against
multiplication of organisms at the alveolar level. The normal
alveolar flora may have a defensive role against respiratory
pathogens. If these defense mechanisms fail to contain the
local multiplication of organisms, the macrophage will produce
a series of cytokines to bring new phagocytes to the alveolar
space (Figure 3). Alveolar epithelia cells are likely involved in
the production of local cytokines in the context of pneumonia.
Local production of cytokines will generate an inflammatory
response with increased local microvascular permeability.
This will facilitate the movement of neutrophils, lymphocytes,
dendritic cells, red blood cells, platelets, proteins, and fluid
into the alveolar space. The presence of this alveolar exudate
will aid the macrophages in the killing of alveolar pathogens.
This process characterizes the initial pulmonary inflammatory
response or local inflammatory response (Figure 4).
As a consequence of the local production of cytokines and
chemokines, these mediators will spill into the systemic
circulation and serve as a way for the lung to communicate
with a series of organs such as the liver, bone marrow, brain,
and spleen. During these interactions, the lung will submit
and receive inputs and generate an integrated systemic
inflammatory response. The liver will produce an acute phase
response, characterized primarily by hepatocyte production of

C-reactive protein. The bone marrow will produce neutrophils
and other cells necessary to migrate into the alveolar space.
The brain thermoregulatory center will elevate the body
temperature. The spleen will produce the appropriate
immunoglobulins according to the antigenic characteristics of
the pulmonary pathogen. All of this lung orchestrated local and
systemic inflammatory responses are considered a normal host
physiologic response to the growth of pathogenic organisms in
the alveolar space (Figure 5). The physiologic abnormalities
produced by the local and systemic host inflammatory response
will explain most of the clinical and laboratory abnormalities in
patients with pneumonia.

Pathophysiology of CAP with Sepsis
In some patients the initial physiologic systemic inflammatory
response can become dysregulated. This abnormal response
will be associated with tissue injury and organ dysfunction.
The progression from a physiologic to a dysregulated systemic
inflammatory response indicates that pneumonia is now
complicated with sepsis [5]. When a patient with CAP develops
sepsis, the patient will have a more severe clinical picture. From
a pathogenesis point of view, it can be considered that when a
patient with CAP advances to sepsis, then the patient has severe
CAP (Figure 6).
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appropriate pulmonary and systemic inflammatory response.
If this physiologic response failed to control the pulmonary
infection, the immune system compromises. On one hand,
the immune system produces an exaggerated inflammatory
response in an attempt to control the pulmonary infection, on
the other hand, the same inflammatory response will produce
organ dysfunction. At this point the patient will have a clinical
picture of severe CAP and will have evidence of sepsis. Patients
with CAP and a persistent dysregulated inflammatory response
may develop septic shock, ARDS, or MODS. Categorizing the
severity of CAP using a pathophysiologic approach may help us
to better study new treatment strategies.

Figure 7. Progression of the dysregulated inflammatory response will
present clinically as a patient with severe CAP plus septic shock, and/or
ARDS, culminating with MODS.
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